FM SEPTEMBER 2018 ISSUE - digital edition
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
web platform.<br />
As the use of the<br />
internet is becoming more<br />
widespread in the semi-urban<br />
parts of India, providing<br />
consultations via the web<br />
will help internet users<br />
access healthcare services<br />
via multiple devices including<br />
mobile, laptops and desktops,<br />
according DocsApp.<br />
Started in 2015, DocsApp<br />
has a user base of over<br />
3.5 million customers<br />
and provides 75,000+<br />
consultations per month. The<br />
app connects patients to<br />
specialist doctors across 19<br />
specialities within 30 minutes<br />
on the app via chat or call.<br />
DocsApp allows patients to<br />
order medicines and lab tests<br />
from home.<br />
DocsApp received the<br />
‘App of the year 2017’ award<br />
from Amazon in the medical<br />
category.<br />
Sanofi Pasteur<br />
launches 4-strain<br />
flu vac in India<br />
Sanofi Pasteur, the vaccine<br />
division of Sanofi,<br />
launched its four-strain<br />
influenza vaccine FluQuadri<br />
in India.<br />
FluQuadri will be India’s<br />
first quadrivalent vaccine to<br />
provide broader protection<br />
against influenza to<br />
population above 3 years of<br />
age, the company said.<br />
The majority of seasonal<br />
influenza vaccines currently<br />
available are trivalent. They<br />
offer protection against two<br />
A strains and one single B<br />
lineage (B/Victoria or B/<br />
Yamagata) of the influenza<br />
virus. However, over recent<br />
flu seasons, co-circulation<br />
of both B lineages has been<br />
consistently observed, making<br />
it difficult for the World<br />
Health Organization (WHO)<br />
to recommend which B strain<br />
should be incorporated in<br />
trivalent influenza vaccines.<br />
Given the change in<br />
epidemiology, quadrivalent<br />
vaccination represent the<br />
next logical step.<br />
India has also seen<br />
circulation of type B influenza<br />
strains. The Integrated<br />
Disease Surveillance Program<br />
(IDSP) annual report of 2017<br />
stated that in the wake of<br />
high number of influenza<br />
deaths and cases in Gujarat,<br />
an expert committee noted<br />
that one of the main reasons<br />
of flu epidemic in Gujarat<br />
Dr Mohan receives Harold Rifkin Award for diabetes care<br />
Dr V Mohan, chairman and<br />
chief of diabetology<br />
at Dr Mohan’s Diabetes<br />
Specialities Centre, has<br />
received the prestigious<br />
Harold Rifkin Distinguished<br />
International Service in the<br />
Cause of Diabetes Award<br />
by the American Diabetes<br />
Association (ADA).<br />
Dr Mohan, who is also<br />
the president and chief of<br />
diabetes research of the<br />
Madras Diabetes Research<br />
Foundation, is the first<br />
Indian doctor to receive this<br />
award.<br />
Dedicated to the memory<br />
of Dr Harold Rifkin, an<br />
internationally recognised<br />
clinician, researcher and<br />
educator in diabetes, the<br />
award is one of the highest<br />
scientific achievement<br />
awards of American<br />
Diabetes Association, given<br />
was that during last year,<br />
the H3N2 and B subtypes<br />
of influenza virus were<br />
circulating, but not H1N1,<br />
leading to a build-up of the<br />
susceptible population.<br />
The WHO includes<br />
quadrivalent influenza<br />
vaccines in its<br />
recommendations.<br />
Philips launches<br />
India’s Future<br />
Health Index <br />
The first <strong>edition</strong> of India’s<br />
Future Health Index (FHI),<br />
a research-based platform<br />
by Royal Philips to help<br />
determine the readiness of<br />
Dr Mohan<br />
annually to an individual<br />
whose efforts have increased<br />
the awareness of the<br />
burden of diabetes<br />
worldwide to improve the<br />
care and lives of those with<br />
diabetes.<br />
The award recognises<br />
Dr Mohan’s outstanding<br />
countries to address global<br />
health challenges and build<br />
sustainable, fit-for-purpose<br />
national health systems has<br />
been launched.<br />
Lack of access due<br />
to low skilled-physician<br />
density and a low number of<br />
hospital beds impede value<br />
the most, according to FHI.<br />
The study also found that<br />
despite a lower-than-average<br />
data analytics score, Indian<br />
healthcare professionals are<br />
open to the use of futuristic<br />
technology (AI, virtual reality)<br />
in healthcare, even more so<br />
than the general population.<br />
FHI finds that healthcare<br />
professionals could become<br />
key promoters of connected<br />
care technologies as they<br />
consider themselves highly<br />
knowledgeable about<br />
connected care devices<br />
and believe in a future<br />
where everyone owns them<br />
to manage their health,<br />
potentially boosting data<br />
collection and analytics in<br />
India.<br />
service to the cause of<br />
diabetes in India and his<br />
pioneering work in the field<br />
of diabetes.<br />
The award was conferred<br />
on Dr Mohan during the<br />
78th Scientific Sessions<br />
of the American Diabetes<br />
Association at Orlando<br />
during the National Scientific<br />
Achievement Awards<br />
Presentation Ceremony<br />
held on June 25 at WB4<br />
Convention Centre.<br />
Dr Mohan has worked<br />
tirelessly to address the<br />
challenges of diabetes<br />
in India and developing<br />
countries. He has actively<br />
been involved in government<br />
health policy and advocacy<br />
programmes related to<br />
diabetes, and has served as<br />
the president of the Research<br />
Society for the Study of<br />
Diabetes in India.<br />
<strong>SEPTEMBER</strong> <strong>2018</strong> / FUTURE MEDICINE / 11